DAFNA Capital Management’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

DAFNA Capital Management’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,722	Closed	-$1.05M	–	82
2025 Q2	$1.05M	Hold	12,722	–	–	0.29%	56
2025 Q1	$1.01M	Buy	+12,722	New	+$1.57M	0.29%	57
2020 Q1	–	Sell	-222	Closed	-$3.7M	–	85
2019 Q4	$3.7M	Sell	222 -16	-7%	-$267K	1.27%	21
2019 Q3	$3.84M	Buy	238 +71	+43%	+$1.15M	1.44%	21
2019 Q2	$3.59M	Hold	167	–	–	1.35%	24
2019 Q1	$4.71M	Buy	167 +17	+11%	+$408K	2.03%	14
2018 Q4	$2.23M	Buy	150 +63	+72%	+$1.41M	1.11%	28
2018 Q3	$3.07M	Hold	87	–	–	1.26%	28
2018 Q2	$2.53M	Buy	+87	New	+$3.38M	1.19%	26

Other funds holding YARW

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DAFNA Capital Management's YARW Position: Q3 2025 in Review

DAFNA Capital Management sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q3 2025, closing a stake of 12,722 shares — an estimated $1.05M sold.

DAFNA Capital Management first reported a position in YARW in Q2 2018 and held it in 9 quarters. The position peaked at $4.71M in Q1 2019. 34 funds tracked by Wall St. Rank hold YARW as of Q3 2025.

DAFNA Capital Management reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
DAFNA Capital Management sold 12,722 Yarrow Bioscience, Inc. Common Stock shares in Q3 2025, an estimated $1.05M.
DAFNA Capital Management first reported a position in Yarrow Bioscience, Inc. Common Stock in Q2 2018 and held it in 9 quarters.
DAFNA Capital Management's Yarrow Bioscience, Inc. Common Stock position peaked at $4.71M in Q1 2019.
34 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q3 2025.

Based on DAFNA Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.